Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Cash-Heavy Stock to Target This Week and 2 We Question

1 Cash-Heavy Stock to Target This Week and 2 We Question

NTRA : 200.09 (+2.46%)
RGEN : 116.35 (+2.17%)
REAX : 2.44 (+3.39%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

RGEN : 116.35 (+2.17%)
2 Growth Stocks Set to Flourishand 1 We Turn Down

2 Growth Stocks Set to Flourishand 1 We Turn Down

FTAI : 241.54 (+5.01%)
RGEN : 116.35 (+2.17%)
PANW : 164.05 (+0.68%)
3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar

DHI : 138.82 (+4.28%)
RGEN : 116.35 (+2.17%)
NMRK : 14.55 (+2.03%)
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

AMN : 18.39 (+2.11%)
EVH : 2.49 (-3.49%)
RGEN : 116.35 (+2.17%)
AMPH : 19.23 (-1.38%)
RDNT : 61.74 (+0.41%)
Repligen Corporation to Present at Upcoming March Conferences

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating...

RGEN : 116.35 (+2.17%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

TNDM : 25.09 (+1.09%)
RGEN : 116.35 (+2.17%)
SEM : 16.27 (+0.12%)
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead

3 Reasons to Avoid RGEN and 1 Stock to Buy Instead

RGEN : 116.35 (+2.17%)
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know

Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know

PRVA : 21.52 (+1.32%)
RGEN : 116.35 (+2.17%)
RDNT : 61.74 (+0.41%)
Repligen: Q4 Earnings Snapshot

Repligen: Q4 Earnings Snapshot

RGEN : 116.35 (+2.17%)

Barchart Exclusives

2 Safe Dividend Stocks to Buy and Hold Forever
These are two dividend stocks that you can confidently buy, hold, and forget about for decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.